| Corona Remedies Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 544644 |
NSE Symbol : CORONA |
P/E(TTM) : 63.51 |
|
ISIN Demat : INE02ZQ01018 |
Div & Yield% : 0.45 |
EPS(TTM) : 34.62 |
|
Book Value(₹) : 121.97 |
Market Cap(₹Cr) : 13,447.57 |
Face Value(₹) : 10.00 |
| Particulars | Dec '26 | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 1,403.18 | 1,196.42 | 1,014.47 | 884.05 | 617.33 |
| Other Income | 10.65 | 5.93 | 6.46 | 7.05 | 6.60 |
| Stock Adjustments | -7.05 | 23.74 | 0.78 | 14.51 | 40.57 |
| Total Income | 1,406.78 | 1,226.09 | 1,021.71 | 905.61 | 664.50 |
| EXPENDITURE : | |||||
| Raw Materials | 253.89 | 260.26 | 227.61 | 225.46 | 187.21 |
| Power and Fuel Cost | 5.69 | 6.03 | 5.66 | 3.97 | 3.51 |
| Other Manufacturing Expenses | 11.00 | 6.57 | 6.46 | 4.64 | 7.24 |
| Selling and Administration Expenses | 355.83 | 301.37 | 259.84 | 233.11 | 92.46 |
| Miscellaneous Expenses | 92.36 | 59.81 | 65.58 | 48.63 | 123.00 |
| Employee Benefit Expenses | 403.02 | 346.14 | 295.37 | 254.77 | 226.65 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 284.99 | 245.91 | 161.20 | 135.03 | 24.42 |
| Interest | 6.97 | 10.60 | 14.44 | 4.27 | 4.73 |
| Gross Profit | 278.02 | 235.31 | 146.76 | 130.76 | 19.69 |
| Depreciation | 37.87 | 37.16 | 28.28 | 20.10 | 20.48 |
| Profit Before Tax | 240.15 | 198.15 | 118.48 | 110.66 | -0.79 |
| Current Tax | 51.48 | 44.80 | 18.88 | 26.27 | 0.00 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 3.82 | 4.30 | 9.10 | -0.32 | -0.39 |
| Reported Net Profit | 184.85 | 149.05 | 90.50 | 84.70 | -0.40 |
| Extraordinary Items | -14.73 | -0.53 | -0.71 | 0.11 | 0.18 |
| Adjusted Net Profit | 199.58 | 149.58 | 91.21 | 84.59 | -0.58 |
| Adjustment below Net Profit | 0.11 | -0.87 | -1.67 | -0.45 | 0.00 |
| Profit/Loss Balance carried down | 502.98 | 377.43 | 305.55 | 228.27 | 236.00 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 44.71 | 22.63 | 16.94 | 6.97 | 7.33 |
| P & L Balance carried down | 643.23 | 502.98 | 377.43 | 305.55 | 228.27 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 100.00 | 73.10 | 37.00 | 27.70 | 0.00 |
| Dividend Per Share(Rs) | 10.00 | 7.31 | 3.70 | 2.77 | 0.00 |
| Earnings Per Share-Unit Curr | 30.22 | 24.37 | 14.80 | 13.85 | -0.08 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 121.97 | 99.04 | 78.51 | 66.70 | 62.86 |
| Book Value(Adj)-Unit Curr | 121.97 | - | - | - | - |
